The Association of Southeast Asian Nations (ASEAN) is a geo-political and economic organisation comprising of Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Laos and Vietnam. Established in 1967, the group has been instrumental in promoting the region’s economic growth and development. Collectively, the group has established economic links and entered into free trade agreements with various countries including China, Japan, South Korea, India, Australia and New Zealand. With a combined nominal GDP of over 2T USD, ASEAN as a bloc is presently the eighth largest economy in the world.
The individual healthcare markets within ASEAN are at different stages of development. For instance, Singapore has arguably the most developed and efficient healthcare system in the region. Among its ASEAN peers, it also spends the most annually on healthcare on a per capita basis – at levels similar to those of advanced economies like Israel and Portugal.
The heterogeneity of the ASEAN healthcare market, coupled with its large size, offers tremendous opportunities to broad range of medical device companies. Governments in the region share the common desire to enhance their healthcare systems and provide better quality care to their people.
Singapore occupies a unique position within ASEAN, being the smallest yet most advanced country within the region. Given Singapore’s close proximity and trade linkages with other Asian countries, it also plays an important role as a sales and marketing gateway into the region. The availability of management talents who are familiar with the region, excellent transport and communications infrastructure, a transparent business environment and the ease of doing business, are just some of the factors that have convinced companies such as Becton Dickinson, Siemens and Medtronics to establish their regional or international HQs in Singapore, specifically to drive their business expansion in Asia.
This one of a kind event will give you the opportunity to discuss in a round table format with industry peers, moderated by Lance Little, Managing Director at Roche Diagnostics Asia Pacific.
Event limited to 20 seats only.